Latest Licensing News

Acrux Limited has secured a further $0.46 million advance on its FY25 R&D Tax Incentive, bringing total advances to $2.19 million and supporting its pharmaceutical product development and working capital needs.

Pro Medicus has secured a landmark 10-year, A$170 million contract to deploy its cloud-based Visage 7 imaging platform across UCHealth’s extensive hospital network in the US Rocky Mountain region.

Lithium Universe has completed legal due diligence on its acquisition of New Age Minerals, securing exclusive rights to a patented solar panel recycling technology. This move positions the company to expand its sustainable footprint in the lithium supply chain.

BPH Global has launched a focused R&D collaboration with Temasek Polytechnic to develop seaweed-based bio-stimulants aimed at boosting growth and yields in Southeast Asia's oil palm and rice sectors. Early talks are also underway for a production facility in Indonesia to commercialize these innovations.

Carnavale Resources reports strong diamond and RC drilling results at its Kookynie Gold Project, extending mineralisation depth and strike at Swiftsure and Tiptoe lodes. An updated resource estimate and scoping study are due in September, underpinning advancing development plans.

MedAdvisor Limited has entered a binding agreement to sell its ANZ business division and intellectual property to Jonas Software for a headline price of $35 million plus an uncapped earn-out. The deal marks a strategic pivot as MedAdvisor focuses on its US operations.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

C29 Metals has exited its Kazakhstan operations to focus on advancing its Mayfield Copper & Gold Project in Queensland, securing a three-year exploration license extension and confirming strong geological potential.

Magmatic Resources has completed the first stage of acquiring the Weebo Gold Project in Western Australia, securing key exploration licenses and gearing up for immediate drilling programs.

Mesoblast has secured FDA agreement on key requirements for its Biologics License Application for Revascor, targeting ischemic heart failure patients with reduced ejection fraction. The company aims for accelerated approval by year-end 2025.

Vanguard Investments Australia has announced estimated distribution amounts for a broad range of its ETFs, alongside key dates for July 2025. Investors can now anticipate income details and plan for upcoming payments across multiple funds.

Aldoro Resources has reported significant assay results confirming a substantial northward extension of mineralisation at its Kameelburg Niobium and Rare Earth Elements deposit. The company is also expanding its drilling program and acquiring new rigs to deepen exploration.